Filtros : "Ebbs, Aaron" Removido: "Salviatto, Armando Padilha" Limpar

Filtros



Refine with date range


  • Source: Journal of Biological Chemistry. Unidade: IQ

    Subjects: PROTEÍNAS QUINASES, GENES SUPRESSORES

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      DAN, Han C et al. Akt-dependent activation of mTORC1 complex involves phosphorylation of mTOR (Mammalian target of rapamycin) by IκB Kinase α (IKK α). Journal of Biological Chemistry, v. 289, n. 36, p. 25227-25240, 2014Tradução . . Disponível em: https://doi.org/10.1074/jbc.M114.554881. Acesso em: 05 set. 2024.
    • APA

      Dan, H. C., Ebbs, A., Pasparakis, M., Dyke, T. V., Bassères, D. S., & Baldwin, A. S. (2014). Akt-dependent activation of mTORC1 complex involves phosphorylation of mTOR (Mammalian target of rapamycin) by IκB Kinase α (IKK α). Journal of Biological Chemistry, 289( 36), 25227-25240. doi:10.1074/jbc.M114.554881
    • NLM

      Dan HC, Ebbs A, Pasparakis M, Dyke TV, Bassères DS, Baldwin AS. Akt-dependent activation of mTORC1 complex involves phosphorylation of mTOR (Mammalian target of rapamycin) by IκB Kinase α (IKK α) [Internet]. Journal of Biological Chemistry. 2014 ; 289( 36): 25227-25240.[citado 2024 set. 05 ] Available from: https://doi.org/10.1074/jbc.M114.554881
    • Vancouver

      Dan HC, Ebbs A, Pasparakis M, Dyke TV, Bassères DS, Baldwin AS. Akt-dependent activation of mTORC1 complex involves phosphorylation of mTOR (Mammalian target of rapamycin) by IκB Kinase α (IKK α) [Internet]. Journal of Biological Chemistry. 2014 ; 289( 36): 25227-25240.[citado 2024 set. 05 ] Available from: https://doi.org/10.1074/jbc.M114.554881
  • Source: Genes & Cancer. Unidade: IQ

    Subjects: ONCOGENES, NEOPLASIAS DO TRATO RESPIRATÓRIO

    Acesso à fonteHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      BASSÈRES, Daniela Sanchez et al. IKK is a therapeutic target in KRAS-induced lung cancer with disrupted p53 activity. Genes & Cancer, v. 5, n. 1-2, p. 41-55, 2014Tradução . . Disponível em: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4063255/pdf/ganc-05-041.pdf. Acesso em: 05 set. 2024.
    • APA

      Bassères, D. S., Ebbs, A., Cogswell, P. C., & Baldwin, A. S. (2014). IKK is a therapeutic target in KRAS-induced lung cancer with disrupted p53 activity. Genes & Cancer, 5( 1-2), 41-55. Recuperado de http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4063255/pdf/ganc-05-041.pdf
    • NLM

      Bassères DS, Ebbs A, Cogswell PC, Baldwin AS. IKK is a therapeutic target in KRAS-induced lung cancer with disrupted p53 activity [Internet]. Genes & Cancer. 2014 ; 5( 1-2): 41-55.[citado 2024 set. 05 ] Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4063255/pdf/ganc-05-041.pdf
    • Vancouver

      Bassères DS, Ebbs A, Cogswell PC, Baldwin AS. IKK is a therapeutic target in KRAS-induced lung cancer with disrupted p53 activity [Internet]. Genes & Cancer. 2014 ; 5( 1-2): 41-55.[citado 2024 set. 05 ] Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4063255/pdf/ganc-05-041.pdf
  • Source: Resumos. Conference titles: Reunião Anual da Federação de Sociedades de Biologia Experimental. Unidade: IQ

    Assunto: NEOPLASIAS PULMONARES

    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      AOKI, M et al. The IKK'beta' kinase is a potential therapeutic target in K-Ras-induced lung cancer. 2011, Anais.. São Paulo: FeSBE, 2011. . Acesso em: 05 set. 2024.
    • APA

      Aoki, M., Ebbs, A., Baldwin, A. S., & Bassères, D. S. (2011). The IKK'beta' kinase is a potential therapeutic target in K-Ras-induced lung cancer. In Resumos. São Paulo: FeSBE.
    • NLM

      Aoki M, Ebbs A, Baldwin AS, Bassères DS. The IKK'beta' kinase is a potential therapeutic target in K-Ras-induced lung cancer. Resumos. 2011 ;[citado 2024 set. 05 ]
    • Vancouver

      Aoki M, Ebbs A, Baldwin AS, Bassères DS. The IKK'beta' kinase is a potential therapeutic target in K-Ras-induced lung cancer. Resumos. 2011 ;[citado 2024 set. 05 ]
  • Source: Cancer Research. Unidade: IQ

    Assunto: NEOPLASIAS PULMONARES

    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      BASSÈRES, Daniela Sanchez et al. Requirement of the NF-'capa' B subunit p65/RelA for 'capa'-Ras-induced lung tumorigenesis. Cancer Research, v. 70, n. 9, p. 3537-3546, 2010Tradução . . Acesso em: 05 set. 2024.
    • APA

      Bassères, D. S., Ebbs, A., Levantini, E., & Baldwin, A. S. (2010). Requirement of the NF-'capa' B subunit p65/RelA for 'capa'-Ras-induced lung tumorigenesis. Cancer Research, 70( 9), 3537-3546.
    • NLM

      Bassères DS, Ebbs A, Levantini E, Baldwin AS. Requirement of the NF-'capa' B subunit p65/RelA for 'capa'-Ras-induced lung tumorigenesis. Cancer Research. 2010 ; 70( 9): 3537-3546.[citado 2024 set. 05 ]
    • Vancouver

      Bassères DS, Ebbs A, Levantini E, Baldwin AS. Requirement of the NF-'capa' B subunit p65/RelA for 'capa'-Ras-induced lung tumorigenesis. Cancer Research. 2010 ; 70( 9): 3537-3546.[citado 2024 set. 05 ]

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024